Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S MOTRIN versus PROFENAL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S MOTRIN versus PROFENAL.
CHILDREN'S MOTRIN vs PROFENAL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, thereby decreasing pain, fever, and inflammation.
Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis, thereby exerting analgesic, anti-inflammatory, and antipyretic effects.
200-400 mg orally every 6-8 hours as needed; maximum 1200 mg/day without prescription, extended release forms: 600-800 mg orally twice daily.
600 mg orally every 6 to 8 hours as needed for pain; or 1000 mg orally every 6 to 8 hours for antipyresis; maximum single dose 1000 mg, maximum daily dose 4000 mg.
None Documented
None Documented
2-4 hours in children; prolonged in neonates and hepatic impairment.
6-8 hours (terminal); requires dosing every 6-8 hours to maintain therapeutic levels
Renal (90%) as inactive metabolites and conjugates; fecal (<5%).
Primarily renal (approximately 70% as metabolites, <5% unchanged), biliary/fecal (30%)
Category C
Category C
NSAID
NSAID